Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
A Lack of Government Transparency: The Devil In The Detailing
Cowritten by Jeff Stier. A House Appropriations subcommittee has voted to move forward legislation that would cut $1.3 billion from the Department of Health and…
Orange County Register
A Losing Proposition on Food Labeling
California's initiative process – which allows "propositions" to be placed on the ballot quite easily – can lead to laws that are muddled, intentionally misleading…
Orange County Register
A Conservative Case for Obamacare?
From Thomas P. Miller’s column in National Review: The response of roughly half of the Senate Republicans was to co-sponsor an alternative bill…
Forbes
Labeling Of Genetically Engineered Foods Is A Losing Proposition
As Joe Six-pack munches Fritos and popcorn during the opening games of the NFL season, does he care what variety of corn was used to…
Boston Herald
Mass. biotech reaps Monsanto deal
From Ira Kantor's article in The Boston Herald: Gregory Conko, senior fellow at the Competitive Enterprise Institute in Washington, D.C., and co-author of…
Real Clear Policy
More FDA Control Does Not Mean More Safety
News outlets are reporting that the U.S. Food and Drug Administration (FDA) has cited an alarmingly high number of alleged safety and regulatory violations by…